selinexor,ruxolitinib
novartis,karyopharm therapeutics,incyte
['mpnsm', 'rux,(-crux),(-trux),(-deruxtecan)', 'selinexor', 'xport,mf,034', '#mpn', 'ruxolitinib', 'xport,mf,34', 'rux,(-crux),(-trux)']
congress|#asco23|poster
haris ali , presents the updated xport-mf-034 trial results showing that 60mg selinexor plus ruxolitinib demonstrated rapid and deep spleen responses across all subgroups, and was well tolerated in treatment-na ve pts with mf #mpnsm 
Lifting levels of knowledge in myeloproliferative neoplasms (MPN). A global online platform providing latest treatment options and medical information #mpnsm